Bioengineered lungs generated from human iPSCs‐derived epithelial cells on native extracellular matrix

The development of an alternative source for donor lungs would change the paradigm of lung transplantation. Recent studies have demonstrated the potential feasibility of using decellularized lungs as scaffolds for lung tissue regeneration and subsequent implantation. However, finding a reliable cell source and the ability to scale up for recellularization of the lung scaffold still remain significant challenges. To explore the possibility of regeneration of human lung tissue from stem cells in vitro, populations of lung progenitor cells were generated from human iPSCs. To explore the feasibility of producing engineered lungs from stem cells, we repopulated decellularized human lung and rat lungs with iPSC‐derived epithelial progenitor cells. The iPSCs‐derived epithelial progenitor cells lined the decellularized human lung and expressed most of the epithelial markers when were cultured in a lung bioreactor system. In decellularized rat lungs, these human‐derived cells attach and proliferate in a manner similar to what was observed in the decellularized human lung. Our results suggest that repopulation of lung matrix with iPSC‐derived lung epithelial cells may be a viable strategy for human lung regeneration and represents an important early step toward translation of this technology.

[1]  Concepcion R. Nierras,et al.  The promise of human induced pluripotent stem cells for research and therapy , 2008, Nature Reviews Molecular Cell Biology.

[2]  B. Stripp,et al.  Building and maintaining the epithelium of the lung. , 2012, The Journal of clinical investigation.

[3]  Xi Ren,et al.  Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix. , 2014, The Annals of thoracic surgery.

[4]  Yvonne Will,et al.  Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  D. Amadori,et al.  Isolation of stem/progenitor cells from normal lung tissue of adult humans , 2009, Cell proliferation.

[6]  D. Kotton,et al.  Next-generation regeneration: the hope and hype of lung stem cell research. , 2012, American journal of respiratory and critical care medicine.

[7]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[8]  Laura E Niklason,et al.  Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. , 2013, Journal of Clinical Investigation.

[9]  R. Strieter,et al.  Stem cells and chronic lung disease. , 2007, Annual review of medicine.

[10]  Chad A. Cowan,et al.  Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. , 2012, Cell stem cell.

[11]  H. Snoeck,et al.  Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. , 2012, Cell stem cell.

[12]  Y. Moodley,et al.  When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine. , 2017, American journal of respiratory cell and molecular biology.

[13]  K. Sermon,et al.  Efficient differentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells. , 2008, Reproductive biomedicine online.

[14]  X. Ren,et al.  Bioengineering Lungs for Transplantation. , 2016, Thoracic surgery clinics.

[15]  Zhen W. Zhuang,et al.  Tissue-Engineered Lungs for in Vivo Implantation , 2010, Science.

[16]  H. Ott,et al.  Bioartificial tissues and organs: are we ready to translate? , 2011, The Lancet.

[17]  G. Vunjak‐Novakovic,et al.  Highly efficient generation of airway and lung epithelial cells from human pluripotent stem cells , 2013, Nature Biotechnology.

[18]  T. V. van Kuppevelt,et al.  Regenerative medicine for the respiratory system: distant future or tomorrow's treatment? , 2013, American journal of respiratory and critical care medicine.

[19]  B. Brockway,et al.  β-Catenin–SOX2 signaling regulates the fate of developing airway epithelium , 2012, Journal of Cell Science.

[20]  Aaron M Zorn,et al.  Vertebrate endoderm development and organ formation. , 2009, Annual review of cell and developmental biology.

[21]  X. Ren,et al.  Regenerative potential of human airway stem cells in lung epithelial engineering. , 2016, Biomaterials.

[22]  Harald C Ott,et al.  Organ engineering based on decellularized matrix scaffolds. , 2011, Trends in molecular medicine.

[23]  C. Schaniel,et al.  Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells , 2011, Nature Biotechnology.

[24]  J. Polak,et al.  Derivation of type II alveolar epithelial cells from murine embryonic stem cells. , 2002, Tissue engineering.

[25]  H. Kubo Tissue engineering for pulmonary diseases: Insights from the laboratory , 2012, Respirology.

[26]  A. Burns,et al.  A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[27]  Stephen F Badylak,et al.  RETRACTED: Engineered whole organs and complex tissues , 2012, The Lancet.

[28]  Elizabeth A. Calle,et al.  Production of decellularized porcine lung scaffolds for use in tissue engineering. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[29]  Kevin Weiss,et al.  Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. , 2012, American journal of respiratory and critical care medicine.

[30]  Scott H Randell,et al.  Human nasal and tracheo-bronchial respiratory epithelial cell culture. , 2013, Methods in molecular biology.

[31]  Angela Panoskaltsis-Mortari,et al.  Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. , 2010, Tissue engineering. Part A.

[32]  D. Warburton,et al.  Cell-based therapies for lung disease. , 2012, British medical bulletin.

[33]  Elizabeth A. Calle,et al.  Strategies for lung regeneration , 2011 .

[34]  T. Editors Retraction—Engineered whole organs and complex tissues , 2018, The Lancet.

[35]  Gordon Keller,et al.  Development of definitive endoderm from embryonic stem cells in culture , 2004, Development.

[36]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[37]  B. Hogan,et al.  Notch-dependent differentiation of adult airway basal stem cells. , 2011, Cell stem cell.

[38]  M. Zern,et al.  Differentiation and Characterization of Metabolically Functioning Hepatocytes from Human Embryonic Stem Cells , 2010, Stem cells.

[39]  J. Bates,et al.  Stem cells and cell therapies in lung biology and diseases: conference report. , 2013, Annals of the American Thoracic Society.

[40]  Christian Schuetz,et al.  Regeneration and orthotopic transplantation of a bioartificial lung , 2010, Nature Medicine.

[41]  K. McCurry,et al.  Lung Transplantation in the United States, 1998–2007 , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  T. Jensen,et al.  Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds , 2013, Respirology.

[43]  Laura E Niklason,et al.  Bioreactor for the Long-Term Culture of Lung Tissue , 2011, Cell transplantation.

[44]  B. Hogan,et al.  Epithelial stem cells of the lung: privileged few or opportunities for many? , 2006, Development.

[45]  J. Rossant,et al.  Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein , 2012, Nature Biotechnology.

[46]  E. Kroon,et al.  Efficient differentiation of human embryonic stem cells to definitive endoderm , 2005, Nature Biotechnology.